Device Partnership
Continuous Glucose Monitoring with Real-Time Cloud Integration
Dexcom's CGM sensors — G6, G7, and Stelo — deliver 288 glucose readings per day via cloud API integration with CCN Health's clinical platform. Real-time glucose trends, predictive alerts, and comprehensive diabetes management without fingersticks.
Platform Overview
Glucose data every 5 minutes.
Dexcom CGMs provide the most granular glucose data available — 288 readings per day, delivered to CCN Health's clinical platform via real-time cloud API.
Platform Integration
The CCN Health platform.
Dexcom device readings flow into CCN Health's clinical platform for real-time monitoring, alerting, and automated EHR documentation.
Dexcom
CCN Health Platform
How It Works
From sensor to clinical insight.
Dexcom CGM data flows through Dexcom's cloud platform to CCN Health via secure API integration — delivering continuous glucose trends without manual patient interaction.
Sensor Measurement
Dexcom's subcutaneous sensor measures interstitial glucose levels continuously, generating a new reading every 5 minutes automatically.
Mobile Relay
The sensor transmits readings via Bluetooth to the patient's smartphone or Dexcom receiver, which syncs to Dexcom's cloud platform.
Cloud API Integration
CCN Health's platform pulls glucose data from Dexcom's cloud API in real time — 288 data points per day with trend direction and rate of change.
Clinical Processing
CCN Health processes glucose trends, calculates time-in-range metrics, generates alerts for hypo/hyperglycemia, and posts data to the patient's EHR.
Clinical Capabilities
Beyond spot-check glucose.
Dexcom CGM data combined with CCN Health's clinical platform unlocks glucose insights that traditional meters cannot provide.
Time-in-Range Analytics
Calculates the percentage of time glucose stays within target range (70-180 mg/dL). The gold-standard metric for diabetes management beyond HbA1c.
Trend Direction & Velocity
Real-time trend arrows show whether glucose is rising, falling, or stable — and how quickly. Enables proactive intervention before crisis events.
Predictive Alerts
Configurable alerts for urgent low, low, high, and rising/falling trends. CCN Health escalates critical glucose events to care teams in real time.
Ambulatory Glucose Profile
14-day and 30-day AGP reports visualize glucose patterns across the full day — revealing dawn phenomenon, post-meal spikes, and overnight trends.
CMS Compliance
Continuous data transmission satisfies CPT 99454 device transmission day requirements. CGM readings automatically document qualifying RPM interactions.
EHR Integration
Glucose summaries, AGP reports, and time-in-range metrics post directly to the patient's EHR record for seamless clinical documentation.
CGM Lineup
Dexcom sensors in the CCN Health ecosystem.
Dexcom's CGM portfolio connects to CCN Health via cloud API integration — providing continuous glucose data for diabetes RPM programs.
| Device | Connectivity | Data Synced |
|---|---|---|
| Dexcom G7 | Bluetooth → cloud API | Glucose every 5 min, trend arrows, rate of change, 10.5-day sensor (15-day variant available), MARD 8.2%, 30-min warm-up |
| Dexcom G6 | Bluetooth → cloud API | Glucose every 5 min, trend arrows, urgent low alerts, 10-day sensor, auto-applicator — discontinuing July 2026 |
| Dexcom Stelo | Bluetooth → cloud API | Over-the-counter CGM, 15-day sensor, no prescription required, for Type 2 (non-insulin) and pre-diabetes |
Device Gallery
Continuous glucose monitoring lineup.
Dexcom's CGM sensors deliver 288 glucose readings per day at 5-minute intervals — factory calibrated with no fingersticks required. Cloud API integration with CCN Health for real-time clinical data.
Dexcom G6 CGM System
FDA iCGM-cleared continuous glucose monitor delivering real-time glucose readings every 5 minutes. Factory calibrated with no fingersticks, 10-day sensor wear, and urgent low alerts. Bluetooth transmission to smartphone with cloud API sync to CCN Health.
Dexcom G7
Next-generation CGM — 60% smaller than G6 with a MARD of 8.2%. Delivers glucose readings, trend direction, and rate of change every 5 minutes. Extended 10.5-day sensor wear with a 15-day variant available. 30-minute warm-up vs G6's 2-hour wait.
Dexcom Stelo
Over-the-counter CGM for glucose awareness and daily pattern tracking. Designed for people with Type 2 diabetes not on insulin — providing glucose trends and daily insights without a prescription.
About Dexcom
Pioneer in continuous glucose monitoring.
Dexcom (NASDAQ: DXCM) is the global leader in continuous glucose monitoring technology, headquartered in San Diego, California. Founded in 1999, Dexcom's CGM sensors are FDA-cleared with iCGM classification and are used by millions of people with diabetes in over 60 countries. The G7 sensor — 60% smaller than G6 with a MARD of 8.2% — represents the latest generation, with an extended 10.5-day wear period and a new 15-day sensor variant. Dexcom Stelo, their first over-the-counter CGM, expands access to people with Type 2 diabetes not on insulin. Dexcom's cloud API enables seamless integration with CCN Health for real-time glucose data, trend analytics, and predictive alerts.